The global medical technology (medtech) industry grew by 5% in 2016, a pace last seen before the financial crisis. This strong performance was fueled by mergers and acquisition (M&A) and portfolio optimization strategies, as well as continued focus on capital efficiency and research and design (R&D) investments, according to Pulse of the industry, the 2017 … More Global medtech revenue bounces back, though focus on sustainable growth must continue
Read the full press release here. Business confidence is high among European middle-market organizations, despite geopolitical uncertainty within and outside Europe, demographic shifts and rapid digitization across sectors according to the EY Growth Barometer: Europe. The study reveals that almost four in ten (38%) European middle-market companies are targeting current year growth of 6% to … More European middle-market organizations forecast their growth to outpace the eurozone over next 12 months
Global M&A activity among telecommunications (telco) companies reflects the ongoing transformation impacting the sector in response to increasing competitive intensity, evolving consumer behaviors and disruption from so-called “over-the-top” (OTT) players, which deliver audio, video or other media over the internet without the involvement of a multiple system operator in the control or distribution of the … More Data privacy considerations in telecommunications M&A: do you know your risk?
Read more on our Global Newsroom. The global mergers and acquisitions (M&A) market remained strong during the first half of 2017, despite rising protectionist sentiment and increasing intervention in deals by governments and regulators. The outlook for the remainder of the year and beyond is positive, particularly with private equity (PE) investors returning to the … More New deal terrain is no barrier for traditional players as global M&A activity remains strong
It was supposed to be a bad year for biotech. For this sector, the simplest of truisms has always held: what goes up must eventually come down. Markets peaked in 2015 and declined in 2016; payer pressure and US election year rhetoric weighed on the sector; drug approvals fell sharply; and biotech companies faced a … More Beyond borders: Biotechnology report 2017 – Staying the course
About this study The EY Global Corporate Divestment Study focuses on how companies should approach portfolio strategy, improve divestment execution and future-proof their remaining business amid massive market disruptions. The 2017 study results are based on more than 900 interviews with corporate executives between October and December 2016 conducted by FT Remark, the research and … More Global Corporate Divestment Study 2017: can divesting help you capitalize on disruption?
Read the full press release on EY’s Global Newsroom. Global mergers and acquisitions (M&A) activity continues to gain strength following heightened dealmaking in the first quarter of 2017, according to the EY 16th Global Capital Confidence Barometer (CCB). Ongoing geopolitical uncertainty has not dented deal appetite among executives. Based on a survey of more than … More Economic confidence and growth imperative overshadow geopolitical concerns and spur further M&A
The second edition of the EY BaroMed report is a barometer for foreign direct investment across the “Euromed region.” The 28 countries that we include in this report as part of the Euromed region share a common history and are bound by mutual flows of trade, investment and migration. Read more here. In a world … More EY BaroMed 2017: Attractiveness of the Mediterranean, Middle East and Gulf region for foreign investment
This article was first published to betterworkingworld.ey.com. The EY Global Corporate Divestment Study reveals that being reactive to disruption isn’t always the best portfolio management strategy Geopolitical uncertainty is on the rise, while technological disruption continues to transform entire business models. Some companies are now faced with competitors they never saw coming this time last … More In times of uncertainty, what are the right reasons to divest?
The global technology sector experienced unprecedented divestment activity in 2016, according to the technology findings from the EY Global Corporate Divestment Study. The volume of global technology divestments valued at more than US$100m grew 37% from 2015 to 2016. Mega-divestments, valued at more than US$1b, rose by 300% last year to 28, up from just … More Global technology divestments grew 37% in the last year, driven by digital transformation